Ionis Pharmaceuticals Inc. Common Stock vs Direxion Daily FTSE China Bull 3x Shares — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.04B), while Direxion Daily FTSE China Bull 3x Shares trades at $24.45 (market cap $600.54M). The key difference: Ionis Pharmaceuticals Inc. Common Stock is far larger — about 11.7× Direxion Daily FTSE China Bull 3x Shares's market cap, and Direxion Daily FTSE China Bull 3x Shares is more actively traded (729,546 versus 2,977,440). Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Direxion Daily FTSE China Bull 3x Shares for 26 Days on average.
| IONS | YINN | |
|---|---|---|
Market Cap | $7.04B | $600.54M |
Volume | 2,977,440 | 729,546 |
Sector | Health | Leveraged / Inverse |
52-Week High | $86.50 | $52.69 |
52-Week Low | $42.38 | $21.45 |
Typical Hold Time | 0 Days | 26 Days |
Enterprise Value | $6.60B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
YINN trades at $25.06, up 0.36% with bearish technical signals from moving averages. The stock shows neutral momentum oscillators with RSI at 44.85. Recent news highlights China's economic policies affecting Asian markets, though YINN's specific financial metrics remain undisclosed in current data. The stock faces concentrated support/resistance around $25.
Outlook remains cautious with technical indicators suggesting bearish pressure. Investment opportunity depends on China's economic recovery and policy developments. Key risks include regulatory changes and market volatility. Analyst consensus and institutional positioning data are currently unavailable for assessment.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →YINN is a leveraged ETF that seeks daily investment results, before fees and expenses, of 300% (3x) of the daily performance of the FTSE China 50 Index. It is a tactical instrument designed for sophisticated traders seeking to magnify short-term bullish views on large-cap Chinese equities, primarily those trading on the Hong Kong Stock Exchange.
Read more on YINN →